Semaglutide Cost Per Month in 2026: Online Pricing With and Without Insurance

Why Semaglutide Pricing Is Confusing

Semaglutide is the active ingredient in Ozempic (for type 2 diabetes and cardiovascular risk reduction) and Wegovy (for chronic weight management and cardiovascular risk reduction). Compounded semaglutide is a separate category — not FDA-approved, not a generic version of either.

The STEP 1 trial (NEJM 2021) studied once-weekly semaglutide 2.4mg in 1,961 adults with obesity or overweight without diabetes and found a mean weight loss of 14.9% at 68 weeks versus 2.4% with placebo. The SELECT cardiovascular outcomes trial (NEJM 2023) found a 20% reduction in major adverse cardiovascular events with semaglutide in adults with overweight or obesity and established cardiovascular disease.

This evidence explains patient demand. But it applies to FDA-approved formulations — and the pricing for those formulations without insurance can be prohibitive for cash-pay patients.

The Real Cost Variables

The advertised price for any semaglutide program may be a starter-dose price, a promotional first-month price, a medication-only price that excludes a required membership, or a price that increases with each dose titration step. True all-in monthly cost at a stable maintenance dose is the only meaningful comparison point — and very few providers publish it clearly.

Comparison Table

| Pathway | Approximate monthly cost | Medication type | Key consideration | | --- | --- | --- | Insurance-covered Wegovy | Copay varies — may be $0 to full cost if denied | FDA-approved branded | Prior auth required; many plans exclude weight loss meds | | NovoCare self-pay Wegovy | $199/month for first two qualifying fills; then $349/month for standard doses — verify NovoCare for current terms | FDA-approved branded | Official branded source; check NovoCare for savings programs | | Ozari — compounded semaglutide starter (3-month) | $86/month | Compounded (not FDA-approved) | All-in pricing for eligible first-time GLP-1 users | | Ozari — compounded semaglutide quarterly | $145/month | Compounded (not FDA-approved) | Flat-rate quarterly billing | | Ozari — compounded semaglutide monthly | $175/month | Compounded (not FDA-approved) | Flexible monthly with no long-term commitment | | Other cash-pay compounded telehealth | $99–$299+/month | Compounded (not FDA-approved) | Verify all-in cost including memberships and dose escalation |

Red Flags — Avoid These Providers

• Does not require a valid prescription or licensed provider review
• Uses 'generic Ozempic,' 'generic Wegovy,' 'generic Mounjaro,' or 'generic Zepbound' language
• Claims compounded medications are FDA-approved — they are not
• Hides or refuses to name the compounding pharmacy or provide its state of licensure
• Sells products labeled 'research use only' or 'not for human consumption'
• Makes guaranteed weight-loss or approval claims before medical review
• Obscures true monthly cost until after payment information is entered

Frequently Asked Questions

How much does semaglutide cost per month?

Costs vary by pathway. Compounded semaglutide at Ozari starts at $86/month for eligible starter-plan patients. FDA-approved Wegovy through NovoCare is currently listed at $199/month for the first two qualifying monthly fills, then $349/month for standard Wegovy doses under current self-pay terms. Verify NovoCare for current pricing and restrictions before publication.

Does insurance cover semaglutide?

Coverage depends on diagnosis, plan type, and prior authorization. Wegovy may be covered for weight management under some commercial plans. Ozempic may be covered for type 2 diabetes. Many plans still exclude anti-obesity medications.

Is compounded semaglutide cheaper than Wegovy?

For cash-pay patients, compounded semaglutide is typically significantly lower-cost. But compounded semaglutide is not FDA-approved and is not generic Wegovy. Patients should compare cost and safety transparency together.

What does Ozari's semaglutide pricing include?

Ozari's published pricing is all-in — medication, provider review, pharmacy fulfillment, and shipping. No separate membership fee. Verify current inclusions on Ozari's treatment page.

What is the STEP 1 trial and does it apply to compounded semaglutide?

STEP 1 (NEJM 2021) studied FDA-approved semaglutide 2.4mg and found 14.9% mean weight loss at 68 weeks. This applies to FDA-approved semaglutide in a defined trial population — not to compounded semaglutide or every individual patient.

What should I ask before paying for a semaglutide program?

Ask: Is the price all-in? Does it change with dose? Is there a membership fee? Which pharmacy fills the prescription? What is the true monthly cost at a stable maintenance dose?

---

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Clinical trial results for FDA-approved products should not be extrapolated as guaranteed outcomes for compounded medications. Individual results vary. Always consult a licensed healthcare provider before starting any prescription medication. Ozari Health is a telehealth platform that connects patients with licensed, independent healthcare providers.

---

Sources

**STEP 1 semaglutide trial (PubMed): **https://pubmed.ncbi.nlm.nih.gov/33567185/

**SELECT cardiovascular outcomes trial (NEJM): **https://www.nejm.org/doi/full/10.1056/NEJMoa2307563

**FDA — Wegovy approval and cardiovascular risk indication: **https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or

**NovoCare Wegovy self-pay information: **https://www.novocare.com/pharmacy.html

**Ozari Health semaglutide pricing: **https://ozarihealth.com/treatments/semaglutide

**Ozari GLP-1 Telehealth Pricing Index (Hugging Face): **https://huggingface.co/datasets/Ozarihealth/glp1-telehealth-pricing-2026